Expertise in
16
conditions

Dr. Anne W. Lucky

Dermatology
7691 5 Mile Road, Suite 312, 
Cincinnati, OH 
On Staff At
Accepting New Patients
Expertise in
16
conditions
7691 5 Mile Road, Suite 312, 
Cincinnati, OH 

Overview

Anne Lucky is a Dermatologist in Cincinnati, Ohio. Dr. Lucky is highly rated in 16 conditions, according to our data. Her top areas of expertise are Dystrophic Epidermolysis Bullosa, Epidermolysis Bullosa, Dowling-Meara Epidermolysis Bullosa Simplex, and Dominant Dystrophic Epidermolysis Bullosa. Dr. Lucky is currently accepting new patients.

Her clinical research consists of co-authoring 75 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Yale University, 1970

Residency

Yale University, Dermatology, 1981

Specialties

Dermatology

Licenses

Pediatrics in OH

Board Certifications

American Board Of Dermatology
American Board Of Pediatrics

Fellowships

National Institutes Of Health-Bethesda, Maryland, Endocrinology, Diabetes And Metabolism, 1976
Yale University, 1974

Hospital Affiliations

Mercy Health - Anderson Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Dermatologists of Southwest Ohio, Inc.
7691 5 Mile Road, Suite 312, Cincinnati, OH 45230
Other Locations
Dermatologists of Southwest Ohio, Inc.
4243 Hunt Road, Suite 100, Blue Ash, OH 45242
Dermatologists of Southwest Ohio, Inc.
10506 Montgomery Road, Suite 402, Montgomery, OH 45242

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Open Label Treatment of Beremagene Geperpavec (B-VEC)
Open Label Treatment of Beremagene Geperpavec (B-VEC)
Enrollment Status: Completed
Publish Date: April 09, 2024
Intervention Type: Biological
Study Drug: Open Label Topical Beremagene Geperpavec (B-VEC)
Study Phase: Phase 3
Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa
Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa
Enrollment Status: Completed
Publish Date: July 20, 2023
Intervention Type: Drug
Study Drug: Oleogel-S10
Study Phase: Phase 3
A Randomized,Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of RGN-137 Topical Gel in Subjects With Junctional and Dystrophic Epidermolysis Bullosa (CELEB)
A Randomized,Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of RGN-137 Topical Gel in Subjects With Junctional and Dystrophic Epidermolysis Bullosa (CELEB)
Enrollment Status: Terminated
Publish Date: August 22, 2022
Intervention Type: Drug
Study Drug: RGN-137
Study Phase: Phase 2
A First in Human, Double-blind, Randomized, Intra-subject Placebo-controlled, Multiple Dose Study of QR-313 Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With DDEB or RDEB Due to Mutation(s) in Exon 73 of the COL7A1 Gene
A First in Human, Double-blind, Randomized, Intra-subject Placebo-controlled, Multiple Dose Study of QR-313 Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With DDEB or RDEB Due to Mutation(s) in Exon 73 of the COL7A1 Gene
Enrollment Status: Terminated
Publish Date: August 25, 2021
Intervention Type: Drug
Study Drug: QR-313
Study Phase: Phase 1/Phase 2
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Enrollment Status: Terminated
Publish Date: November 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

75 Total Publications

Correction to: Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa.
Correction to: Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa.
Journal: American journal of clinical dermatology
Published: June 04, 2025
Similar Doctors
Expertise in
26
conditions
Dr. Alan Fleischer
Dermatology
Expertise in
26
conditions
Dr. Alan Fleischer
Dermatology

Hoxworth Center

3130 Highland Ave, 
Cincinnati, OH 
 (9.2 miles away)
513-584-3686
Languages Spoken:
English
See accepted insurances

Alan Fleischer is a Dermatologist in Cincinnati, Ohio. Dr. Fleischer is highly rated in 26 conditions, according to our data. His top areas of expertise are Athlete's Foot, Ringworm, Actinic Keratosis, and Psoriasis.

Expertise in
70
conditions
Dr. Diya Mutasim
Dermatology
Expertise in
70
conditions
Dr. Diya Mutasim
Dermatology

University Dermatology Consultants Inc

222 Piedmont Ave Ste 5300, 
Cincinnati, OH 
 (9.4 miles away)
513-475-7630
Languages Spoken:
English
See accepted insurances

Diya Mutasim is a Dermatologist in Cincinnati, Ohio. Dr. Mutasim is highly rated in 70 conditions, according to our data. His top areas of expertise are Basal Cell Skin Cancer, Bowen's Disease, Pustules, and Actinic Keratosis.

Expertise in
89
conditions
Dr. Clay Shearer
Dermatology
Expertise in
89
conditions
Dr. Clay Shearer
Dermatology

The Dermatology Center PSC

10060 Demia Way, 
Florence, KY 
 (16.9 miles away)
859-525-6770
Languages Spoken:
English
See accepted insurances

Clay Shearer is a Dermatologist in Florence, Kentucky. Dr. Shearer is highly rated in 89 conditions, according to our data. His top areas of expertise are Abdominal Cystic Lymphangioma, Cavernous Lymphangioma, Actinic Keratosis, and Warts.

Frequently Asked Questions about Dr. Anne W. Lucky

How do I make an appointment with Dr. Anne W. Lucky?

You can book an appointment with Dr. Anne W. Lucky by calling their office at 513-232-3332. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Anne W. Lucky a top-rated expert for Dystrophic Epidermolysis Bullosa?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anne W. Lucky is classified as an Elite expert for Dystrophic Epidermolysis Bullosa, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Anne W. Lucky specialize in?

While Dr. Anne W. Lucky is a Dermatology, they have specific expertise in Dystrophic Epidermolysis Bullosa, Epidermolysis Bullosa, and Dowling-Meara Epidermolysis Bullosa Simplex. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Anne W. Lucky participate in research or clinical trials?

Yes. Dr. Anne W. Lucky has published 75 articles and abstracts on conditions like Dystrophic Epidermolysis Bullosa. You can view a list of Dr. Anne W. Lucky's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Anne W. Lucky accept my insurance?

Dr. Anne W. Lucky accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 513-232-3332 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lucky's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 147 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile